An additional 75 lakh beneficiaries under the PM Ujjwala scheme, the third phase of eCourts program, and a foreign direct investment proposal to the tune of up to Rs 9,589 crore in Suven Pharmaceuticals Limited by Berhyanda Limited of Cyprus were among the decisions taken by the Union Cabine
The Union Cabinet Committee on Economic Affairs, chaired by Prime Minister Narendra Modi, on Wednesday approved the Foreign Direct Investment proposal for the investment of up to Rs 9,589 crore in Suven Pharmaceuticals Limited by Berhyanda Limited of Cyprus.
The Competition Commission of India (CCI) approved the acquisition of up to 76.10 per cent of the voting share capital of Suven Pharmaceuticals Limited by Berhyanda Limited, said a press release on Thursday.
Mumbai (Maharashtra)/ New Delhi [India], January 3 (ANI/BusinessWire India): Cyril Amarchand Mangaldas advised the promoters of Suven Pharmaceuticals Limited (Suven Pharmaceuticals) in relation to the acquisition of Suven Pharmaceuticals by global private equity firm Advent, for an aggregate
As part of the transaction, Advent said it would also be making an open offer to acquire additional 26 per cent of the outstanding equity shares of the company from the public shareholders.